Hypoxic-ischemic (HI) brain injury is frequently associated with premature and/or full-term birth-related complications that reflect widespread damage to cerebral cortical structures. Inflammation has been implicated in the long-term evolution and severity of HI brain injury. Inter-Alpha Inhibitor Proteins (IAIPs) are immune modulator proteins that are reduced in systemic neonatal inflammatory states. We have shown that endogenous IAIPs are present in neurons, astrocytes and microglia and that exogenous treatment with human plasma purified IAIPs decreases neuronal injury and improves behavioral outcomes in neonatal rats with HI brain injury. In addition, we have shown that endogenous IAIPs are reduced in the brain of the ovine fetus shortly after ischemic injury. However, the effect of HI on changes in circulating and endogenous brain IAIPs has not been examined in neonatal rats. In the current study, we examined changes in endogenous IAIPs in the systemic circulation and brain of neonatal rats after exposure to HI brain injury. Postnatal day 7 rats were exposed to right carotid artery ligation and 8% oxygen for 2 h. Sera were obtained immediately, 3, 12, 24, and 48 h and brains 3 and 24 h after HI. IAIPs levels were determined by a competitive enzyme-linked immunosorbent assay (ELISA) in sera and by Western immunoblots in cerebral cortices. Serum IAIPs were decreased 3 h after HI and remained lower than in non-ischemic rats up to 7 days after HI. IAIP expression increased in the ipsilateral cerebral cortices 24 h after HI brain injury and in the hypoxic contralateral cortices. However, 3 h after hypoxia alone the 250 kDa IAIP moiety was reduced in the contralateral cortices. We speculate that changes in endogenous IAIPs levels in blood and brain represent constituents of endogenous anti-inflammatory neuroprotective mechanism(s) after HI in neonatal rats.
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Introduction
Hypoxic-Ischemic (HI) brain injury is a result of decreased blood flow to the brain combined with lower-than-normal oxygen concentrations in arterial blood (Dixon et al., 2015; Mehta et al., 2007) . HI related events in premature and full-term infants increase mortality and result in long-term neurological deficits including cerebral palsy, epilepsy and seizure disorders, severe learning and mental impairment, cognitive, motor and behavioral developmental problems (Conklin et al., 2008; Fatemi et al., 2009; Kharoshankaya et al., 2016; Pappas et al., 2015) . The only currently available strategy to attenuate brain injury in newborns is therapeutic hypothermia (Gluckman et al., 2006; Jacobs et al., 2013; Natarajan et al., 2016; Shankaran, 2012) . This therapy is only approved for use in full-term newborns with hypoxic ischemic encephalopathy (HIE) and, unfortunately, is only partially neuroprotective (Gluckman et al., 2006; Jacobs et al., 2013; Natarajan et al., 2016; Shankaran, 2012) .
Post-ischemic neuroinflammation is a key pathophysiological factor in the evolution of HI-related brain injury (Ferriero, 2004; Hagberg et al., 2015; Lai et al., 2017; Riljak et al., 2016; Rocha-Ferreira and Hristova, 2016) . The first phase of HI injury lasts minutes to hours after the initial insult and is marked by oxidative stress and depletion of energy stores. The second phase of HI injury occurs from hours to days after the insult and is characterized by an intense neuroinflammatory response. This neuroinflammatory response is associated with the release of several pro-inflammatory cytokines/chemokines, recruitment of proteases, activation of resident immune cells (e.g. microglia) and infiltration of circulating immune cells (e.g. circulating monocytes)
